Ceribell (CBLL) Return on Capital Employed (2024 - 2026)

Ceribell (CBLL) reported Return on Capital Employed of 10.4% for Q1 2026, up 1150.0% on a YoY basis from 0.83% in Q1 2025, and down 65.44% quarter-over-quarter from 6.28% in Q4 2025.

Ceribell (CBLL) Return on Capital Employed (2024 - 2026) Analysis & Trends

Ceribell has reported Return on Capital Employed for 3 years, with the latest figure at 10.4% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Capital Employed rose 1150.0% year-over-year to 10.4%; the trailing twelve-month figure through Mar 2026 stood at 10.4% (up 1150.0% YoY), and the FY2025 full-year result was 5.86%, up 2488.0% from the prior year.
  • Return on Capital Employed for Q1 2026 stood at 10.4%, down from 6.28% in the prior quarter.
  • The five-year high for Return on Capital Employed was 6.28% in Q4 2025, with the low at 32.22% in Q4 2024.
  • Historically, Return on Capital Employed has averaged 21.24% across 3 years, with a median of 24.24% in 2025.
  • Annual changes were most pronounced in 2025 — Return on Capital Employed soared 2593 bps — and 2026, when it soared 1150 bps.
  • Ceribell's Return on Capital Employed stood at 32.22% in 2024, then jumped by 80 bps to 6.28% in 2025, then slumped by 65 bps to 10.4% in 2026.
  • The last three Return on Capital Employed figures came in at 10.4% (Q1 2026), 6.28% (Q4 2025), and 30.08% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 9.61%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 12.24%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 7.36%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 9.62%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 11.13%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 9.30%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 10.45%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 24.24%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 11.57%
10 Ceribell 695.83 Mn 554.65 Mn 23.12 Mn -10.40%

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.40%
Dec 31, 2025 -6.28%
Sep 30, 2025 -30.08%
Jun 30, 2025 -26.58%
Mar 31, 2025 -21.90%
Dec 31, 2024 -32.22%